Empli Met Xr 12.5/2.5/1000mg Tab 30s
Empagliflozin, Linagliptin, and Metformin XR for type 2 diabetes.
Empli Met Xr 12.5/2.5/1000mg is a triple combination of empagliflozin 12.5mg (SGLT2 inhibitor), linagliptin 2.5mg (DPP-4 inhibitor), and metformin 1000mg (extended-release). Used for type 2 diabetes as an adjunct to diet and exercise. Take once daily in the morning with a meal. Swallow whole. Pack of 30 tablets.
Purpose
Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise.
Ingredients
Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin hydrochloride 1000mg (extended-release) per tablet.
Warnings
Contraindicated in severe renal impairment, diabetic ketoacidosis. Risk of lactic acidosis. Not for type 1 diabetes.
Side Effects
Genital and urinary tract infections, nausea, diarrhea. Rare: lactic acidosis (metformin), ketoacidosis.
Storage Instructions
Store below 25°C in a dry place. Keep in original pack to protect from moisture.
| Brand | Horizon |
| Status | Active |
Related Products
